Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|August 28, 2023
Bilateral orbital plasmacytomas as first sign of extramedullary progression post CAR-T therapy: case report and literature reviewJavier Nogués-Castell, Silvia Feu-Basilio, Óscar Felguera García, et al.
Blood Advances|December 6, 2024
Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cellsAnthony M Battram, Joan Mañé-Pujol, David F Moreno, et al.
Blood Cancer Journal|September 16, 2022
Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institutionRaquel Jiménez-Segura, Laura Rosiñol, Ma Teresa Cibeira, et al.
British Journal of Haematology|October 8, 2021
Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year periodLuis Gerardo Rodríguez-Lobato, Arturo Pereira, Carlos Fernández de Larrea, et al.
Cancers|November 14, 2023
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single InstitutionLuis Gerardo Rodríguez-Lobato, Natalia Tovar, Anna de Daniel, et al.
Hemasphere|May 8, 2024
The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myelomaAnna de Daniel, Luis Gerardo Rodríguez-Lobato, Natalia Tovar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2020
Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple MyelomaEster Lozano, Mari-Pau Mena, Tania Díaz, et al.
Molecular Therapy. Methods & Clinical Development|July 21, 2022
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cellsAnthony M Battram, Aina Oliver-Caldés, Maria Suárez-Lledó, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple MyelomaEster Lozano, Mari-Pau Mena, Glòria Garrabou, et al.
Annals of Hematology|August 31, 2021
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced diseaseIgnacio Isola, David F Moreno, Esther Moga, et al.
Pageof 3